Tritium


Journal

Bioconjugate chemistry
ISSN: 1520-4812
Titre abrégé: Bioconjug Chem
Pays: United States
ID NLM: 9010319

Informations de publication

Date de publication:
19 05 2021
Historique:
pubmed: 29 4 2021
medline: 14 9 2021
entrez: 28 4 2021
Statut: ppublish

Résumé

An efficient procedure to access tritium-labeled maleimide derivatives in a high specific activity has been developed.

Identifiants

pubmed: 33909418
doi: 10.1021/acs.bioconjchem.1c00202
doi:

Substances chimiques

Alcohols 0
Maleimides 0
alkoxyl radical 0
Tritium 10028-17-8
maleimide 2519R1UGP8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1027-1033

Auteurs

Martin R Edelmann (MR)

Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, U.K.
Roche Pharma Research and Early Development, Roche Innovation Center Basel, Therapeutic Modalities, Small Molecule Research, Isotope Synthesis, F. Hoffmann-La Roche Ltd, CH-4070 Basel, Switzerland.

Thorsten Muser (T)

Roche Pharma Research and Early Development, Roche Innovation Center Basel, Therapeutic Modalities, Small Molecule Research, Isotope Synthesis, F. Hoffmann-La Roche Ltd, CH-4070 Basel, Switzerland.

Articles similaires

Triple Negative Breast Neoplasms Tumor Microenvironment Humans Prognosis Female

Discovery, characterization, and synthetic potential of two novel bacterial aryl-alcohol oxidases.

Paula Cinca-Fernando, Christian Ascaso-Alegre, Emma Sevilla et al.
1.00
Alcohol Oxidoreductases Catalytic Domain Crystallography, X-Ray Substrate Specificity Recombinant Proteins
Humans Adenosine Breast Neoplasms Methylation Female
RNA-Binding Protein FUS Fluorescence Resonance Energy Transfer Humans Biomolecular Condensates RNA

Classifications MeSH